However, since CD47 is an essential molecule for protecting normal cells from macrophage attack, strategies for CD47 inhibition need to be very precisely targeted to tumor cells in order to avoid severe collateral damage, as observed with anti-CD47 antibody infusion that causes thrombocytopenia or anemia (35, 45, 46). This evidence concerns the gene CD47 and Thrombocytopenia.